- Home
- AXSM vs LYFT Comparison
AXSM vs LYFT Comparison
Compare AXSM & LYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- LYFT
- Stock Information
- Founded
- AXSM 2012
- LYFT 2007
- Country
- AXSM United States
- LYFT United States
- Employees
- AXSM N/A
- LYFT N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- LYFT Business Services
- Sector
- AXSM Health Care
- LYFT Consumer Discretionary
- Exchange
- AXSM Nasdaq
- LYFT Nasdaq
- Market Cap
- AXSM 4.0B
- LYFT 4.0B
- IPO Year
- AXSM 2015
- LYFT 2019
- Fundamental
- Price
- AXSM $93.19
- LYFT $11.06
- Analyst Decision
- AXSM Strong Buy
- LYFT Buy
- Analyst Count
- AXSM 14
- LYFT 34
- Target Price
- AXSM $125.67
- LYFT $15.93
- AVG Volume (30 Days)
- AXSM 427.1K
- LYFT 12.0M
- Earning Date
- AXSM 11-04-2024
- LYFT 08-07-2024
- Dividend Yield
- AXSM N/A
- LYFT N/A
- EPS Growth
- AXSM N/A
- LYFT N/A
- EPS
- AXSM N/A
- LYFT N/A
- Revenue
- AXSM $291,489,000.00
- LYFT $5,095,182,000.00
- Revenue This Year
- AXSM $42.50
- LYFT $29.78
- Revenue Next Year
- AXSM $69.28
- LYFT $13.26
- P/E Ratio
- AXSM N/A
- LYFT N/A
- Revenue Growth
- AXSM 59.73
- LYFT 19.88
- 52 Week Low
- AXSM $55.02
- LYFT $8.85
- 52 Week High
- AXSM $98.40
- LYFT $20.82
- Technical
- Relative Strength Index (RSI)
- AXSM 64.50
- LYFT 44.10
- Support Level
- AXSM $88.04
- LYFT $11.27
- Resistance Level
- AXSM $97.00
- LYFT $11.89
- Average True Range (ATR)
- AXSM 3.03
- LYFT 0.48
- MACD
- AXSM 0.49
- LYFT 0.06
- Stochastic Oscillator
- AXSM 64.58
- LYFT 13.59
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LYFT Lyft Inc.
Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.